Literature DB >> 31844437

Comparison of the Use of Hypnotic in Psychiatric Patients with Insomnia at the Mental Health Centre Prolet in Skopje.

Viktor Isjanovski1, Igor Isjanovski2.   

Abstract

BACKGROUND: Insomnia is a symptom complex that comprises difficulties falling asleep, staying asleep or non-refreshing sleep in combination with daytime dysfunction or distress. Most people experience insomnia at some time during their lives. Because of its high incidence, and also because its symptoms are usually mild and transient, the importance of insomnia is frequently underestimated. Various conditions are associated with insomnia and can contribute to its development. They can be related to neurological or psychiatric disorders, which in turn may be aggravated by a deficiency of restorative sleep and daytime fatigue. AIM: In this study, the authors compare the hypnotically effect of Flurazepam and Zolpidem applied on psychiatric cases treated in the Mental Health Centre "Prolet" in Skopje, Republic of Macedonia.
METHODS: The investigation covers 45 patients who have insomnia, in addition to their primary mental illness. The examination took six weeks, and it was divided into 3 equal phases. In the first phase of three weeks, Zolpidem was used, and in the third phases, Flurazepam was administrated. We used a self-estimating scale of 13 items and methods of global clinical estimation in the evaluation of received effects.
RESULTS: The results show that referring to the induction of the sleeping period, its duration and quality and the number of awakenings, there are no significant differences between the two medicaments used, but there was a significant difference between hypnotic medicaments and placebo.
CONCLUSION: The termination with the therapy, didn`t lead to the appearance of abstinential symptoms. Copyright:
© 2019 Viktor Isjanovski, Igor Isjanovski.

Entities:  

Keywords:  Flurazepam; Insomnia; Psychiatric patients; Zolpidem

Year:  2019        PMID: 31844437      PMCID: PMC6901857          DOI: 10.3889/oamjms.2019.711

Source DB:  PubMed          Journal:  Open Access Maced J Med Sci        ISSN: 1857-9655


  15 in total

1.  Comparative tolerability, pharmacodynamics, and pharmacokinetics of a metabolite of a quinolizinone hypnotic and zolpidem in healthy subjects.

Authors:  J Dingemanse; M Bury; Y Hussain; P van Giersbergen
Journal:  Drug Metab Dispos       Date:  2000-12       Impact factor: 3.922

2.  National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005.

Authors: 
Journal:  Sleep       Date:  2005-09       Impact factor: 5.849

Review 3.  Chronic insomnia.

Authors:  Charles M Morin; Ruth Benca
Journal:  Lancet       Date:  2012-01-20       Impact factor: 79.321

4.  Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.

Authors:  Maurizio Fava; Gregory M Asnis; Ram K Shrivastava; Bruce Lydiard; Bijan Bastani; David V Sheehan; Thomas Roth
Journal:  J Clin Psychiatry       Date:  2010-12-28       Impact factor: 4.384

5.  Physiological and psychological differences between good and poor sleepers.

Authors:  K Adam; M Tomeny; I Oswald
Journal:  J Psychiatr Res       Date:  1986       Impact factor: 4.791

6.  Clinical significance of prescribing hypnotics in general practice.

Authors:  D Wheatley
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

Review 7.  Insomnia.

Authors:  Maryann C Deak; John W Winkelman
Journal:  Neurol Clin       Date:  2012-11       Impact factor: 3.806

Review 8.  Insomnia causes, consequences, and therapeutics: an overview.

Authors:  Christopher L Drake; Timothy Roehrs; Thomas Roth
Journal:  Depress Anxiety       Date:  2003       Impact factor: 6.505

Review 9.  Could agomelatine be the ideal antidepressant?

Authors:  S R Pandi-Perumal; Venkatramanujan Srinivasan; D P Cardinali; M J Monti
Journal:  Expert Rev Neurother       Date:  2006-11       Impact factor: 4.618

Review 10.  The effect of melatonergic and non-melatonergic antidepressants on sleep: weighing the alternatives.

Authors:  Seithikurippu R Pandi-Perumal; Ilya Trakht; Venkataramanujan Srinivasan; D Warren Spence; Burkhard Poeggeler; Ruediger Hardeland; Daniel P Cardinali
Journal:  World J Biol Psychiatry       Date:  2009       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.